TRURAPI
TRURAPI
Approved
DIN Number
02506564
Drug Class
Human
Market Date
Mar 30, 2021
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02506564
AIG Number0144802001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
A10AB05 INSULIN ASPART
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
INSULIN ASPARTActive
Strength: 100 UNIT / ML
Monograph: INSULIN ASPART